Market research
PFIZER.NSE Pfizer Limited
NSE INR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 228B
- P/E ratio
- 30.96
- Analyst target
- 6658.5
- Dividend yield
- 0.0%
- Beta
- 0.12
Community
Investor discussion
1 comment
Sign in to join the PFIZER.NSE discussion.
5 years, 5 months ago
Pfizer Limited is currently in a long term uptrend where the price is trading 13.4% above its 200 day moving average.
From a valuation standpoint, the stock is 98.4% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 9.5.
Pfizer Limited's total revenue rose by 5.0% to $6B since the same quarter in the previous year.
Its net income has dropped by 14.8% to $1B since the same quarter in the previous year.
Finally, its free cash flow grew by 54.2% to $3B since the same quarter in the previous year.
Based on the above factors, Pfizer Limited gets an overall score of 3/5.